Wednesday, November 03, 2021 5:30:42 PM
English report out on @enzolytics patented #ipf. Effective and non toxic.https://t.co/rb4H9r0jG8
— BEAUMAN (@bowzachary) October 22, 2021
Here's the test results report on enzc ipf that will be used in the treatment. 35 times less toxic than several current treatments.
$ENZC “When comparing the experimental data on cell survival, it became clear that the following antiviral drugs widely used as positive controls in antiviral experiments: acyclovir Remdesivir, Tamiflu and hydroxychloroquine are about 35 times more toxic than IPF” @enzolytics pic.twitter.com/zncTdLc22T
— BEAUMAN (@bowzachary) October 22, 2021
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM